| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $753.8M | +0.7% |
| Cost of Revenue | $458.8M | -2.1% |
| Gross Profit | $295.1M | +5.4% |
| R&D Expense | $132.5M | +11.7% |
| SG&A Expense | $75.2M | +4.9% |
| Operating Income | -$14.4M | +28.4% |
| Interest Expense | $2.4M | -18.8% |
| Income Tax | -$3.7M | -51.5% |
| Net Income | -$12.9M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.8M | +25.6% |
| Short-term Investments | $8.5M | +329.2% |
| Accounts Receivable | $91.4M | +5.7% |
| Current Assets | $219.1M | +16.6% |
| Total Assets | $1.05B | +6.4% |
| Current Liabilities | $154.1M | +9.8% |
| Long-term Debt | $247.6M | -12.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $89.5M | +6.7% |
| Investing Cash Flow | -$39.1M | -2608.5% |
| Financing Cash Flow | -$29.1M | +77.9% |
| -97.9% |
| EPS (Basic) | -$0.43 | -79.2% |
| EPS (Diluted) | -$0.43 | -79.2% |
| Total Liabilities |
| $652.7M |
| -3.5% |
| Stockholders' Equity | $400.0M | +28.0% |